Skip to main content

Adma Biologics, Inc.

ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001368514

No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.

Q1 2023 vs. Q4 2022

How the institutions holding Adma Biologics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of ADMA: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders1604163+7
Shares152.6M80.1K165.3M+12.8M (+8.4%)
Value$592.2M$310.9K$547.2M−$44.6M (−7.5%)

4 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Adma Biologics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to ADMA in Q1 2023
InstitutionSharesValue% of portfolio
American Century Companies Inc1,115,270$3.68M0.00%
Globeflex Capital L P236,323$782.2K0.10%
Hillsdale Investment Management Inc.205,700$680.9K0.06%
Profund Advisors LLC182,413$603.8K0.04%
CWM Advisors, LLC163,182$540.1K0.07%
UBS Asset Management Americas Inc138,128$457.2K0.00%
Marshall Wace, LLP114,900$380.3K0.00%
EWG Elevate Inc.100,000$331.0K0.14%
PFG Investments, LLC87,500$289.6K0.06%
Group One Trading, L.P.80,127$265.2K0.01%
Maven Securities LTD50,000$165.5K0.03%
Mirae Asset Global Investments Co., Ltd.42,623$141.1K0.00%
State of Wyoming41,114$136.1K0.04%
Victory Capital Management Inc23,423$77.5K0.00%
Alberta Investment Management Corp22,273$73.7K0.00%
Cambridge Investment Research Advisors, Inc.21,428$71.0K0.00%
Orion Portfolio Solutions, LLC13,270$43.9K0.00%
Dynamic Technology Lab Private Ltd11,713$39.0K0.00%
Sawtooth Solutions, LLC11,362$37.6K0.00%
Bleakley Financial Group, LLC11,362$37.6K0.00%
Envestnet Asset Management Inc10,442$34.6K0.00%
Tucker Asset Management LLC9,321$30.9K0.01%
Russell Investments Group, Ltd.1,303$4.31K0.00%
Quadrant Capital Group LLC867$2.87K0.00%
WR Wealth Planners, LLC500$1.66K0.00%

Sold out (18)

Institutions that held Adma Biologics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of ADMA in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Norges Bank1,793,300$6.96M
EAM Global Investors LLC836,323$3.24M
HRT Financial LP621,348$2.41M
Pura Vida Investments, LLC300,000$1.16M
Potomac Capital Management, Inc.120,000$466.0K
Walleye Capital LLC44,323$172.0K
Stratos Wealth Partners, LTD.40,035$155.3K
ExodusPoint Capital Management, LP35,632$138.0K
Squarepoint Ops LLC29,334$113.8K
AE Wealth Management LLC20,385$79.1K
Two Sigma Securities, LLC19,440$75.4K
Meridian Wealth Management, LLC17,000$66.0K
HSBC Holdings PLC14,034$54.5K
Money Concepts Capital Corp3,875$15.0K
Cutler Group LP2,000$7.00K
Rockefeller Capital Management L.P.1,399$5.00K
US Bancorp287$1.11K
Ellevest, Inc.115$446

Not filed for Q1 2023 yet (4)

Institutions that held Adma Biologics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ADMA in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Telemetry Investments, L.L.C.57,500$223.0K
Burleson & Company, LLC12,407$48.1K
ARGI Investment Services, LLC10,000$39.0K
Heritage Wealth Management, LLC200$776